AT

Arjun Tewari

Active Director Director DIN 11475312
DIN 11475312 First appointment Jan 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Arjun Tewari

Data last updated:

Arjun Tewari is a Director at Starline Health Private Limited (since 2026) and Designated Partner at Rizzworks Llp (since 2026).

DIN 11475312
Primary Designation Director
First Appointment 09 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Starline Health Private Limited U46497HR2026PTC150823
Director23 Sep 20262026Active
Rizzworks Llp ACU-1681
Designated Partner09 Jan 20262026Active

Board colleagues of Arjun Tewari

NameDINCompanyDesignation
Pratiyusha Tewari10868288Starline Health Private LimitedDirector
Dilip Cherian00322763Rizzworks LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Rizzworks Llp
Starline Health Private Limited
Premium access

Shareholding and investment profile for Arjun Tewari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arjun Tewari

Arjun Tewari currently holds 2 directorships: Starline Health Private Limited (Director, since 23 Sep 2026); Rizzworks Llp (Designated Partner, since 09 Jan 2026).

Arjun Tewari was first appointed on 09 Jan 2026 as Designated Partner at Rizzworks Llp.

The current boards of Arjun Tewari's companies include Pratiyusha Tewari (Starline Health Private Limited), Dilip Cherian (Rizzworks Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available